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Abstract
Neuroimaging studies of depression have demonstrated treatment-specific changes involving the limbic system and
regulatory regions in the prefrontal cortex. While these studies have examined the effect of short-term, interpersonal or
cognitive-behavioural psychotherapy, the effect of long-term, psychodynamic intervention has never been assessed. Here,
we investigated recurrently depressed (DSM-IV) unmedicated outpatients (N=16) and control participants matched for sex,
age, and education (N=17) before and after 15 months of psychodynamic psychotherapy. Participants were scanned at two
time points, during which presentations of attachment-related scenes with neutral descriptions alternated with descriptions
containing personal core sentences previously extracted from an attachment interview. Outcome measure was the
interaction of the signal difference between personal and neutral presentations with group and time, and its association
with symptom improvement during therapy. Signal associated with processing personalized attachment material varied in
patients from baseline to endpoint, but not in healthy controls. Patients showed a higher activation in the left anterior
hippocampus/amygdala, subgenual cingulate, and medial prefrontal cortex before treatment and a reduction in these areas
after 15 months. This reduction was associated with improvement in depressiveness specifically, and in the medial
prefrontal cortex with symptom improvement more generally. This is the first study documenting neurobiological changes
in circuits implicated in emotional reactivity and control after long-term psychodynamic psychotherapy.
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Introduction
Neuroimaging approaches have been used to investigate
neurobiological changes in depressive patients in studies that
address remission after psychotherapy or antidepressant medica-
tion [1–2]. The majority of these studies focused on the effect of
treatment on brain metabolism or perfusion at rest. A more recent
series of functional neuroimaging (fMRI) studies has turned to the
use of experimental tasks to examine processes that may be more
directly involved in emotional appraisal and control processes [3–
6]. To date, studies examining the functional neuroanatomy of
psychotherapy in depressed patients have applied interpersonal
therapy or cognitive behavioural therapy [7–8]. The present
research reports on the first fMRI study with recurrently depressed
patients treated with psychodynamic psychotherapy. Long-term
psychodynamic psychotherapy has been shown to be associated
with larger improvement in these difficult forms of depression than
shorter treatments [9–10].
The interest aroused by neuroimaging studies of treatment of
depression is in part due to their potential importance in shedding
light on the mechanism of therapy. There is considerable evidence
for increased activation in limbic areas in depression, especially the
amygdala, under exposure to emotional stimuli [5–8,11–12]. This
limbic activation may be related to an increased reactivity of
depressed patients to emotional stimuli of negative valence [13]. It
has been proposed that antidepressant medication acts directly on
this abnormal reactivity [1], since amygdalar activation normalizes
in medicated remission [5–6]. However, changes associated with
depression have also been reported for prefrontal regions during
the execution of cognitive tasks [14]. Because of the regulatory
nature of many processes mapped onto the prefrontal cortex, these
changes may refer to mechanisms involved in emotional regulation
during the acute depressive episode, or reflect deficits in cognitive
control [15–16]. Different interpretations of signal changes in the
prefrontal cortex in depression or after therapy may be given [17].
Given that emotion regulation may either have adverse or
protective roles in mental health, depending on the mechanism
through which it operates [18–19], it may be important to
determine not only if, but also how emotions are regulated [20].
Psychodynamic approaches propose that depression, besides its
biological and social underpinnings, may be meaningfully
conceived as a specific organization of an individual’s conscious
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operations constitute defensive strategies that aim at avoiding
negative feelings arising out of conflict in order to maximize a
subjective sense of safety [21]. The objective of long-term
psychodynamic psychotherapy is a stable modification of these
strategies that allows the patient to work through, achieve insight,
and reappraise experiences that are related to depressive
pathology. Therefore, in our study we would expect neural
patterns of appraisal of sensitive material to change during therapy
and move from emotion regulation styles characterized by
unfavourable strategies to more integrated acceptance and
awareness. The identification of these neural patterns was the
general aim of our study.
To date, only one fMRI study has investigated the effect of
psychotherapy (cognitive behavioural therapy) on major depres-
sion using a standardized experimental task (Fu et al., [22]). In this
study, participants were exposed to faces portraying different
degrees of sadness. This study detected changes in the amygdala-
anterior hippocampus and posterior cingulate-precuneus regions
as well as the superior frontal gyrus, suggesting that areas
associated in previous studies with increased reactivity to
emotional stimuli and mechanisms of control are also relevant
for psychotherapy effects.
In the present study, patients with recurrent unipolar depression
underwent functional neuroimaging scans at the beginning of
treatment and after 15 months, during which they were treated
with psychodynamic psychotherapy by experienced therapists. A
matched healthy control group without psychotherapy was
scanned at the same time points. The stimulus materials were
attachment-related pictures from the Adult Attachment Projective
Picture System (AAP [23]), a measure that has been shown to be
valid for use in an fMRI environment [24–25]. These pictures are
designed to elicit mental engagement with attachment-related
experiences such as separation, illness, danger, and loss. The
fundamental ability to form attachment is indispensable for human
social relationships. Since Bowlby’s seminal contributions [26],
attachment and separation have become essential theoretical
components of developmental psychology, and psychodynamic
theory [27]. One key feature of interpersonal problems in
depressed patients is their feelings of helplessness and fear of
losing the love of a significant other [28]. Internal representations
of the self as unlovable and of attachment figures as unloving are a
central dimension of Beck’s cognitive triad of depression [29].
To increase the capacity of the signal to elicit a response related
to the emotional processes of each individual, material was here
prepared using personalized content [11,30–32] derived from
AAP interviews with each participant. In the personally relevant
condition the AAP attachment scenes were accompanied by
individually tailored descriptions containing core sentences from
the patient’s own narrative previously elicited by each picture (see
Material and methods for details). The same series of attachment
scenes accompanied by a standard factual, non-emotional
description for all participants was used as control condition.
In addition to the detection of a neural signature of treatment,
we were interested to see the extent in which the pattern of change
corresponded or differed from the one described by Fu et al. [22].
On the basis of this study, we formulated specific hypotheses
relative to the general aim of the study of characterizing changes in
neural patterns of appraisal and emotion regulation occurring after
therapy. Our first hypothesis was the normalization of emotional
reactivity indexed by changes in the amygdala-anterior hippo-
campus region, as found by Fu et al. [22]. Our second hypothesis
was the existence of changes in prefrontal areas detected in
previous studies [22,31,33] as possible markers of the specific effect
of psychodynamic psychotherapy on styles of emotion regulation
[1,8].
The present design differed from that of previous studies in
several further respects. As mentioned before, neuroimaging
studies have examined the effects of short time psychotherapy
(e.g. 12–20 weeks), applying cognitive-behavioural or interpersonal
therapy [7–8]. We examined depressed patients with a history of
several previous depressive episodes during psychodynamic
treatment providing a longer observation window (15 months of
therapy) than in previous studies.
The present investigation therefore complements the existing
emerging picture of changes associated with the therapy of
depression emerging from neuroimaging studies. In meta-analyses
of neuroimaging studies of the effect of psychopharmacological
intervention [34], decreased activation following treatment was
reported in the anterior hippocampus and parahippocampal
cortex, in the subgenual and pregenual cingulus, in the insula, and
the putamen. In the prefrontal cortex, decreased activation was
reported in the middle and superior left frontal gyrus. The frontal
lobes, however, were also the seat of several meta-analytic foci of
increased activation following treatment (in the middle frontal gyri
bilaterally and the dorsal anterior cingulate cortex). Further
increased activation was found in the posterior cingulate cortex
and in temporo-parietal regions on both sides. With the exception
of Fu et al. [22], neuroimaging studies of psychotherapy of
depression have examined only resting state metabolism (for
reviews, see [7–8,35]). Here, therapy outcomes were associated
primarily with changes in the prefrontal cortex (dorsolateral,
ventrolateral, and medial) [36–38], but the direction of changes
was not entirely consistent. Some studies reported reduced rest
metabolism or perfusion that normalized at endpoint [37–38]. In
other studies, however, this finding was reversed [36]. When both
psychotherapy and pharmacotherapy were compared [37], there
was limited overlap between changes found in these two therapy
modalities. While all these studies appear to be broadly compatible
with the involvement of limbic and prefrontal areas, more studies
of task-related activation are needed to provide a comprehensive
picture of changes associated with remission.
Materials and Methods
The study protocol was approved by the ethical committee of
the University of Ulm and was in compliance with national
legislation, the principles expressed in the Declaration of Helsinki,
and the Code of Ethical Principles for Medical Research Involving
Human Subjects of the World Medical Association. All partici-
pants gave written informed consent.
Participants
Patients were recruited from the outpatient departments of two
psychoanalytic institutes in Bremen, Germany, and diagnosed by
two trained clinicians using the Structured Clinical Interview for
DMS-IV Diagnosis (SCID, German version, [39]). Eight patients
were diagnosed with double depression (dysthymia and former
major depression episodes); in the remaining patients, degree of
depression was severe. Ten patients had a comorbid anxiety
disorder. Patients reported 3–10 previous depressive episodes
(mean 6 episodes, standard deviation 3.4). Age at first occurrence
of depression was between 8 and 37 years (mean 20 years,
standard deviation 9.2). All patients reported previous unsuccessful
psychopharmacological and/or psychotherapeutic treatment
(none of which was psychodynamic). Exclusion criteria were other
psychiatric conditions as main diagnosis, substance abuse,
significant medical or neurological conditions (including medical
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criteria were a long history of recurrent major depression as an
appropriate indication for psychodynamic treatment. Non-
depressed controls were recruited from the community, matched
for age, sex and education; control participants had no history of
previous depressive episodes or other psychiatric conditions
(SCID). Ethical considerations precluded the recruitment of a
depressed group left untreated for the duration of the study. All
participants were right-handed.
Depression severity and general psychological symptoms were
assessed using the Beck Depression Inventory (BDI, [40], German
version [41]) and the Global Severity Index (GSI) from the revised
Symptom Check List (SCL-90-R [42], German version [43]). Of
the initial sample of 38 participants, 5 dropped out of the study (3
controls and 2 patients). The final sample of 33 consisted of 16
patients and 17 controls (7 males, mean age 38.9 years, standard
devaition 12.4, range 20–64). Patients and controls in the final
sample did not differ in age (logistic multiple regression, z=0.41,
p=0.68), sex (z=0.49, p=0.62), and education (z=0.56, p=0.57).
Treatment
Patients were treated with long-term psychodynamic psycho-
therapy by 16 formally trained psychoanalysts (mean years of
experience 22.4, standard deviation 7.9). Training as a psychody-
namic psychotherapist is certified by the German state and
regulated by laws specifying the hours of theory, psychotherapy
under supervision, and self-awareness training. Patients underwent
2 to 4 hours of therapy weekly (2 patients had 4 hours, 7 had
3 hours, and 7 had 2 hours per week). At the end of the study
period of 15 months, patients had received from 90 to 210 hours
of psychotherapy (mean 129 hours, standard deviation 37).
Psychotherapy formally qualified as psychodynamic on the basis
of two criteria. The first was observance of the ‘‘couch setting’’ in
which the patient talks while lying on a couch with no visual
contact with the therapist. The second were the core features of
psychodynamic thinking and therapeutic technique, which include
interventions focusing on the interpretation of the patient’s
unconscious conflicts as they emerge in the transference
relationship [21], and the focus on affect as it emerges in
relationships, in attempts to avoid distressing thoughts, in memory
of past events, and in recurring patterns of interactions [44].
Adherence to these principles was assured by a regular case-
discussion group led by one co-author (GB) in which all
participating therapists presented their patients and interventions.
Participants to this group had no access to the material produced
by patients during the AAP interview and its results used to create
personalized stimuli in the scanner.
All patients were free of psychotropic medication throughout
the entire 15 months of the study by their own choice. After the
end of the study, therapy continued for varying periods of time, for
total therapy lengths ranging between 24 and 48 months in
accordance to individual therapeutic contracts, course of treat-
ment, and health insurance allowance.
Experimental design
Stimuli were derived from the Adult Attachment Projective
Picture System (AAP, [23]), an established and validated interview
to assess attachment patterns. The AAP consists of 7 picture
stimuli, designed to activate the attachment system [25]. Two to
four weeks prior to the fMRI experiment, one trained judge (ST)
conducted a standard AAP interview. Administration involves
asking participants in a semi-structured format to describe the
scene in the picture, including what characters are thinking or
feeling, and what they think might happen next. Three core
sentences that represented the attachment pattern of the
participants were extracted from the audiotaped responses to
each AAP picture stimulus by two independent certified judges
(e.g., ‘‘A girl is incarcerated in that big room’’, ‘‘My mother
suffered until the end and the ambulance came often’’). These
sentences were paired to the respective picture to constitute the
‘‘personally relevant’’ trials tailored to each participant (Figure 1).
The same pictures, paired to sentences describing only the
environment of the depicted situation (e. g. ‘‘There is a window
with curtains on the left and right’’, ‘‘There is a bed with a big
blanket’’) constituted the ‘‘neutral’’ trials, and were identical for all
participants. Each trial consisted of the presentation of the picture-
sentence pair for 5 seconds, followed by a fixation cross between
7.5 and 12.5 seconds. Participants were instructed to mentally
engage with the attachment scene in the picture and its textual
description.
Stimuli were presented in two blocks of six trials each. Each
block contained three different sets of personally relevant sentences
and neutral sentences for each picture stimulus. Trials alternated
between the personally relevant and neutral in groups of seven
AAP picture stimuli. In total, there were 84 trials resulting in a
scanning time of about 21 min. After scanning, participants filled
out a questionnaire that asked to rate on a 7-point Likert scale the
degree of emotional arousal and relevance of the personally related
sentences (emotional arousal is here a construct referring to the
degree to which participants rated personal sentences emotionally
involving, not the degree of depressive symptoms associated with
them). There were no significant differences in the ratings of
patients and controls (t31=0.31, p=0.38), thus suggesting that
differences in neural activation levels between patients and
controls were not driven by higher emotional valence of the
stimuli.
Image acquisition
MRI data were obtained with a 3-T Magnetom Allegra head
scanner (Siemens, Erlangen, Germany), equipped with a standard
quadrature head coil. To reduce anxiety levels, anatomical images
were acquired first (3D high resolution T1-weighted volume,
MPRAGE-sequence; TR/TE/TI=2300/4.38/900 ms, flip an-
gle=8u, FOV=25662566176 mm, isotropic voxel size 1 mm,
total acquisition time 7.5 min). A total of 508 EPI T2*-weighted
whole brain volumes were acquired (TR/TE=2500/30 ms, flip
angle 90u, FOV 192 mm, matrix 64664, voxel size 363 mm, slice
thickness 3 mm, 44 slices, interleaved acquisition order, standard
AC-PC orientation).
Statistical analysis
Data were analyzed and visualized using Brain Voyager
QX1.10 (Brain Innovation, Maastricht, Netherlands). Volumes
were slice-time corrected and realigned to the first volume,
normalized into standard Talairach space with parameters
obtained from the co-registered high-resolution structural vol-
umes, and smoothed with a Gaussian isotropic kernel (8 mm full
width-half maximum). To remove low frequency drifts, data were
high-pass filtered (3 cycles, 3 sine waves within the extent of the
data) and z-transformed in each voxel separately. The BOLD
response function was modeled by convolving the trial onsets with
a standard hemodynamic response function. Motion-correction
parameters were included in the model as confounding covariates
at the first level. Effects of interest were estimated in each subject
separately and brought to the second level to account for a random
effect of subjects. Data were analyzed using a 2 (participant
group)62 (time)62 (sentence) factorial design. The main effect of
interest of the study was the interaction between the main effects of
Neuroimaging and Psychotherapy of Depression
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33745group (patients vs. healthy control subjects) and time (baseline
month 1 vs. endpoint month 15) on the activation detected by the
contrast personally relevant vs. neutral. To identify regions
associated with changes we performed a whole-brain estimation
of the model voxel by voxel, considering a priori clusters larger
than 20 voxels. Because effect sizes obtained in an interaction may
be expected to be small, we relied on the results of Fu et al. [22] to
support inference and considered the extent to which our result
confirmed findings of this previous study. The region of interest
emerging from this study, and from the comparison with the
existing literature on depression and its therapy, were the
amygdala-anterior hippocampus region, and prefrontal areas as
markers of emotion regulation processes [22,31,33], and more
specifically on the medial surface [22], given the inconsistency of
reports on the lateral surface/dorsolateral prefrontal cortex [45].
We report on additional findings with explorative intent.
Anatomical identification of foci relied on publicly available
empirical cytoarchitectonic maps [46–47] where these maps exist
(amygdala and hippocampus). In the regressions of clinical
response on signal changes, confounding by initial conditions
was avoided by including baseline scores (BDI or GSI) and signal
as covariates in the model (as in ref. [31]).
Results
Clinical Response
We first looked at changes in depressive symptoms to ensure
that patients had responded to therapy. BDI scores refer to the
level of depressive symptoms, whereas GSI scores reflect general
symptomatic distress. At baseline, BDI score mean was 24.4
(standard deviation 9.5, range 10 to 40). BDI scores from 10 to 18
suggest mild to moderate depression; from 19 to 29 moderate to
severe depression [48]. At endpoint (i.e. at the time of the second
scan), the mean BDI score was 12.9 (standard deviation 8.2, range
2.5 to 35). Mean reduction in scores was 11.47 (paired t15=4.99,
p,0.001). Mean GSI score at baseline was 1.35 (standard
deviation 0.57, range 0.19 to 2.52), at endpoint 0.69 (standard
deviation 0.36, range 0.16 to 1.41). Mean GSI score reduction was
0.66 (paired t15=5.99, p,0.001). Clinically, five patients still
fulfilled diagnostic criteria for major depressive disorder at
endpoint. All patients were planning at the end of the study to
continue psychotherapy.
At baseline, controls showed scores in the healthy range in both
GSI (mean score 0.18, standard deviation 0.13) and BDI (mean
score 2.17, standard deviation 2.48). GSI and BDI scores did not
change in controls. At endpoint, mean GSI score was 0.13
(standard deviation 0.11) and mean BDI score was 1.94 (standard
deviation 2.36; GSI: paired t16=2.11, p=0.052; BDI: paired
t17=1.07, p=0.299).
Neuroimaging data
The main effect of interest of the study was given by the
interaction between group (patients and controls) and time (pre vs.
post) for the contrast relevant vs. irrelevant, as this interaction
directly detects changes intervening during therapy that affected
patients but not controls in the appraisal of personalized material.
In this interaction an effect in the left amygdala was detected ([46],
Talairach coordinates x, y, z: 233, 211, 224, F1,32=9.00,
p=0.005), extending laterally into the anterior hippocampus
where it reached its peak in Brodmann area (BA) 36 (x, y, z: 233,
214, 225, F1,32=12.11, p=0.001, Figure 2A, red circle), and
towards the middle temporal gyrus. On the right, the interaction
failed to reach significance (x, y, z: 24, 210, 227, F1,32=3.24,
p=0.08), but this was consistent with the general left-lateralized
pattern of activation elicited by the task. Post-hoc analysis revealed
this effect to be due to patients showing more activity than control
Figure 1. Stimuli. Prototypical presentation with personally relevant sentences from the AAP Picture System.
doi:10.1371/journal.pone.0033745.g001
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which equalized or partially reversed at endpoint (t32=22.41,
p=0.01).
An interaction effect was also present in the ventral anterior
cingulate cortex (vACC, x, y, z: 0, 23, 4, BA25, F1,32=6.91,
p=0.013, Figure 2B, blue circle). Post-hoc analysis identified this
interaction as being mainly due to patients activating less when
exposed to self-referential material at endpoint than controls
(t32=22.1, p=0.02), while at baseline the relation was partially
inverted, with patients activating more than controls (t32=1.74,
p=0.05). A fairly large area of interaction involved the medial
prefrontal cortex in a much more dorsal position (x, y, z: 3, 44, 49,
BA8-9, F1,32=13.47, p,0.001, Figure 2B, yellow circle), which
extended onto the lateral aspect in the superior frontal gyrus and
posteriorly reached the middle frontal gyrus. This interaction was
due to cortical activation in patients at baseline relative to controls
(t32=3.00, p=0.003) that equalized at endpoint (t32=21.6, n.s.).
No other clusters of interaction in either direction were present
with a size larger than 150 mm
3 (about 20 voxels), even when
selected at the liberal threshold p,0.05, uncorrected.
Correlation of clinical response and cerebral activity
To verify that the areas detected by the interaction were related
with changes in depressive symptoms, we regressed changes in the
signal of the contrast personally relevant vs. neutral on the
improvement in BDI scores, adjusting for initial levels to avoid
confounding for initial severity. In the hippocampal/amygdalar
cluster, the association was only at trend level (t12=1.29, p=0.11),
accounting for only 12% of the change in the signal from baseline
to endpoint. A stronger association was found in the ventral ACC
(t12=2.19, p=0.02, explained variance 29%, Figure 3A, blue),
which did not change when age and sex were included as
covariates in the analysis (28%). In the medial prefrontal cortex
the association between the interaction effect and clinical response
was not significant (t14=0.92, p=0.19).
Long-term psychodynamic psychotherapy is indicated for the
treatment of chronic depression [9], and may be expected to
address a wide range of issues that may complicate the depressive
illness and contribute to chronicity. For this reason, we extended
our analysis of the association of changes with response to the
Global Severity Index (GSI [42]), a more general index of psychic
well being than BDI. GSI and BDI scores were moderately
associated at baseline (r=0.32, z=1.80, p=0.04, 11% explained
variance), but strongly correlated at endpoint (r=0.87, z=7.04,
p,0.001, 76% of explained variance), suggesting effective
treatment of initial non-depressive symptoms captured by the
GSI score (interaction of the BDI/GSI association with time,
t28=2.36, p=0.01).
As in the previous analysis with BDI scores, there was no
significant association between GSI improvement and the change
in the contrast signal in the hippocampal/amygdalar cluster
(t12=1.08, n.s.). However, a significant association was found in
the ventral ACC cluster (t12=1.77, p=0.05, explained variance
21%), which was not changed by including sex and age as
covariates (20%). As one can see in Figure 3A, the association with
GSI improvement (in red) did not differ much from that of BDI (in
blue). Also in the medial prefrontal cortex there was an association
between the change in the contrast signal and clinical response
measured by GSI (t12=2.05, p=0.03, explained variance 26%),
which remained after including age and sex as confounding
covariates (28%). As shown in Figure 3B, changes in the contrast
signal were more strongly associated with the general improve-
ment measured by GSI (in red) than with recovery from
depression as reflected by the BDI scores (in blue).
Discussion
When exposed to personally attachment-relevant material,
patients undergoing long-term psychodynamic psychotherapy
showed changes in brain activation that were not observed in a
sample of control participants. The significant association of the
changes in the subgenual cingular and medial prefrontal cortex
with symptom improvement supported the hypothesis of their
relevance to the changes intervened during therapy.
Among the areas involved by these changes, the anterior
hippocampus/amygdalar complex has been shown to be impli-
cated in the detection of emotional stimuli [49–52] and displays
Figure 2. Neuroimaging results. Statistical maps of the interaction between contrast ‘relevant’ vs. ‘neutral’, group, and time, overlaid on a
template T1-weighted brain in Talairach space. A: frontal slice showing the interaction in the amygdala/anterior hippocampus (red circle), and B: in
the subgenual cingulus (blue) and in the anteromedial prefrontal cortex (yellow circle). For display purposes, the F map of the interaction was
thresholded at p=0.01, uncorrected.
doi:10.1371/journal.pone.0033745.g002
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[53–56]. The hippocampal/amygdalar correlate of change of the
present study fell within 5–10 mm of the anterior hippocampal
area associated with therapy change by Fu et al. [22] using
cognitive behavioral therapy. Changes in the ventral ACC were
located in the subgenual area reported by previous studies [36–
37,57–59] that provided converging evidence of its critical
involvement in both mood dysregulation and its resolution [60–
61]. Changes over time in both areas consisted of a reduction in
the reactivity of these areas in response to personally relevant
material in patients. This pattern was not observed in controls.
A third area, located anteriorly and superiorly in the medial
prefrontal cortex, was found in the present study to change from
baseline to endpoint in patients and not in controls. This area has
been associated with voluntary emotion regulation [19,62–63]. In
the present study, this area displayed increased activation when
exposed at baseline to personally relevant material in patients, and
equalized at endpoint. Furthermore, changes in this area were
associated with changes in general symptom severity rather than
with changes in depressiveness specifically. This finding is
consistent with research showing this area’s general role in
emotion regulation and control processes.
It is interesting that the prefrontal areas in which changes were
detected in the present study correspond to those associated with
emotion regulation [19,62–63]. Studies of emotional appraisal and
regulation have associated intentional avoidant and emotion
suppression styles with increased psychiatric morbidity and
vulnerability to depression [19]. Because the material in the
present study was carefully chosen to represent personally relevant
attachment themes, we consider the associated emotional
appraisal to reflect the style of affect regulation.
There were several aspects of this study that are worth
commenting. Among its strengths was the extension of neuroim-
aging approaches to the investigation of changes during therapy in
conditions not investigated in previous studies: the recurrent type
of the depression from which patients suffered, the length of
therapy, and the psychodynamic nature of treatment. There were
also several limitations. First, while the personalized design may
have allowed an increase in validity and sensitivity of the stimuli
used in the scanner [11,30–32], it also introduces a possible
confound due to the existence of systematic differences in the
material produced by patients and controls. However, the absence
of differences in the rating of the emotional arousal of these
personalized sentences between patients and controls makes the
existence of this confound less likely. Second, the study lacked a
natural course control group composed by depressed patients on a
waiting list. Given the length of time during which the study was
conducted, keeping recurrent depressive patients on a waiting list
would have been unethical.
The pattern of changes in prefrontal areas found in the present
study may be specifically associated with mechanisms of emotional
appraisal and control, suggesting reduced recourse to styles
characterized by suppression and avoidance after long-term
therapy. This interpretation outlines a possible mechanism for
the understanding of emotional appraisal and regulation in the
psychodynamic psychotherapy of depression. The relevance of
these finding for future studies rests in the possibility of
documenting specific mechanisms of action of depression therapy
by systematically collating results from different studies and
comparing different psychotherapeutic approaches, such as
psychodynamic, behavioral, interpersonal, and psychopharmaco-
logical. This would be a first step towards monitoring progress of
therapy in individual patients.
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